91²Ö¿â

author

 
 

Meta

Ashleigh Furlong
A healthcare worker takes samples from a patient suffering from Ebola.
WORLD / Science & Health
Jun 26, 2026
Ebola scientists lack access to virus samples behind Congo¡¯s largest Bundibugyo outbreak
The issue highlights growing disputes over pathogen sharing and the difficulty of moving infectious materials across borders for research.
Tests for patients suffering from Alzheimer¡¯s disease are displayed at the Memory Center in Geneva in June 2023.
WORLD / Science & Health
Apr 16, 2026
Alzheimer¡¯s drugs targeting amyloid don¡¯t help, review finds
Despite successfully removing amyloid from the brain, the drugs don¡¯t improve cognitive function or slow its decline.
Astellas Pharma Chief Executive Officer Naoki Okamura
BUSINESS / Companies
Mar 11, 2026
Trump¡¯s drug cost push helps Astellas win higher price in Japan
Japan, where medicine prices are among the lowest in the most developed nations, has become a critical reference point in U.S. plans to match drug prices with other countries.
AstraZeneca and Daiichi Sankyo's drug Datroway extended survival in patients with a hard-to-treat form of breast cancer.
BUSINESS / Companies
Oct 7, 2025
Breast cancer patients lived longer on drug Datroway, says maker
The drug is said to have significantly improved survival and delayed disease progression in patients with a particularly hard to treat form of the disease.
Daiichi Sankyo is working on the next generation of targeted cancer drugs.
JAPAN / Science & Health
Sep 17, 2024
Daiichi wants to go it alone in search for targeted cancer drugs
Investors are betting on Daiichi¡¯s continued success, with its share price up 122% in the last five years.
People walk past the AstraZeneca booth during the first China International Supply Chain Expo (CISCE) in Beijing on Nov. 28, 2023.
BUSINESS / Companies
Sep 16, 2024
AstraZeneca¡¯s blockbuster drug scores major win in combatting bladder cancer
In patients with muscle-invasive bladder cancer, the drug Imfinzi reduced the risk of disease recurring by 32% when given alongside the current standard of care.

Longform

Social camouflaging can help neurodivergent people navigate social situations, but researchers say the effort often comes with significant emotional and mental strain.
The challenge of being neurodivergent in Japan¡¯s culture of conformity

SUSTAINABLE JAPAN